Molecular Endocrinology, Vol 9, 1561-1570, Copyright © 1995 by Endocrine Society

ARTICLES

Expression and regulation of steroid 5 alpha-reductase in the urogenital tract of the fetal rat

DM Berman, H Tian and DW Russell
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235-9046, USA.

Two androgens, testosterone and dihydrotestosterone, are required for the development of the male urogenital tract in the rat. Testosterone is secreted by the fetal testes and is thought to elicit differentiation of the Wolffian ducts into seminal vesicles, vas deferens, and epididymides. Testosterone is converted into dihydrotestosterone by steroid 5 alpha-reductase in the urogenital tract, and this conversion is necessary for the differentiation of the prostate and external genitalia. Genes encoding two 5 alpha-reductase isozymes, designated type 1 and type 2, have been identified. We examined the expression and regulation of these genes on days 17-21 in the urogenital tracts of male and female fetuses. Expression of the type 1 gene predominated in epithelial cells, whereas type 2 gene expression was limited to mesenchymal cells. Surprisingly, this expression pattern was detected in both testosterone-dependent and dihydrotestosterone-dependent anlagen of the urogenital tract and was the same in both male and female fetuses. Furthermore, transcripts encoding the two isozymes were present in their respective cell types before the overt differentiation of internal genitalia. Androgens stimulated expression of the type 2 gene in the urogenital tracts of both sexes, but did not effect expression of the type 1 gene or the cell type-specific expression patterns of the 5 alpha-reductase genes. In the adult prostate, 5 alpha-reductase gene expression is under feedforward control, in which the product of the enzyme, dihydrotestosterone, stimulates the expression of the gene. However, no evidence for feedforward regulation of either 5 alpha-reductase gene was detected in the fetus.

This article has been cited by other articles:

				A. Iranmanesh and J. D. Veldhuis Combined Inhibition of Types I and II 5 {alpha}-Reductase Selectively Augments the Basal (Nonpulsatile) Mode of Testosterone Secretion in Young Men J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4232 - 4237. [Abstract] [Full Text] [PDF]

				P. M. D. Foster and M. W. Harris Changes in Androgen-Mediated Reproductive Development in Male Rat Offspring Following Exposure to a Single Oral Dose of Flutamide at Different Gestational Ages Toxicol. Sci., June 1, 2005; 85(2): 1024 - 1032. [Abstract] [Full Text] [PDF]

				K. Ko, H. M. Theobald, R. W. Moore, and R. E. Peterson Evidence that Inhibited Prostatic Epithelial Bud Formation in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Exposed C57BL/6J Fetal Mice Is Not Due to Interruption of Androgen Signaling in the Urogenital Sinus Toxicol. Sci., June 1, 2004; 79(2): 360 - 369. [Abstract] [Full Text] [PDF]

				C. J. Bowman, N. J. Barlow, K. J. Turner, D. G. Wallace, and P. M. D. Foster Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat Toxicol. Sci., August 1, 2003; 74(2): 393 - 406. [Abstract] [Full Text] [PDF]

				N. J. Barlow and P. M.D. Foster Pathogenesis of Male Reproductive Tract Lesions from Gestation Through Adulthood Following in Utero Exposure to Di(n-butyl) Phthalate Toxicol Pathol, June 1, 2003; 31(4): 397 - 410. [Abstract] [PDF]

				P. M.D. Foster and B. S. Mcintyre Endocrine Active Agents: Implications of Adverse and Non-Adverse Changes Toxicol Pathol, January 1, 2002; 30(1): 59 - 65. [Abstract] [PDF]

				M. S. Mahendroo, K. M. Cala, D. L. Hess, and D. W. Russell Unexpected Virilization in Male Mice Lacking Steroid 5{alpha}-Reductase Enzymes Endocrinology, November 1, 2001; 142(11): 4652 - 4662. [Abstract] [Full Text] [PDF]

				B. S. McIntyre, N. J. Barlow, and P. M. D. Foster Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues Toxicol. Sci., August 1, 2001; 62(2): 236 - 249. [Abstract] [Full Text] [PDF]

				A. L. M. Boehmer, A. O. Brinkmann, R. M. Nijman, M. C. T. Verleun-Mooijman, P. de Ruiter, M. F. Niermeijer, and S. L. S. Drop Phenotypic Variation in a Family with Partial Androgen Insensitivity Syndrome Explained by Differences in 5{{alpha}} Dihydrotestosterone Availability J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1240 - 1246. [Abstract] [Full Text]

				H. M. Theobald, B. L. Roman, T.-M. Lin, S. Ohtani, S.-W. Chen, and R. E. Peterson 2,3,7,8-Tetrachlorodibenzo-p-dioxin Inhibits Luminal Cell Differentiation and Androgen Responsiveness of the Ventral Prostate without Inhibiting Prostatic 5{alpha}-Dihydrotestosterone Formation or Testicular Androgen Production in Rat Offspring Toxicol. Sci., December 1, 2000; 58(2): 324 - 338. [Abstract] [Full Text] [PDF]

				M. J. J. Finken, R. C. Andrews, R. Andrew, and B. R. Walker Cortisol Metabolism in Healthy Young Adults: Sexual Dimorphism in Activities of A-Ring Reductases, but not 11{beta}-Hydroxysteroid Dehydrogenases J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3316 - 3321. [Abstract] [Full Text]

				M. S. Mahendroo, A. Porter, D. W. Russell, and R. A. Word The Parturition Defect in Steroid 5{alpha}-Reductase Type 1 Knockout Mice Is Due to Impaired Cervical Ripening Mol. Endocrinol., June 1, 1999; 13(6): 981 - 992. [Abstract] [Full Text]

				M. V. J. Mustonen, V. V. Isomaa, T. Vaskivuo, J. Tapanainen, M. H. Poutanen, F. Stenbäck, R. K. Vihko, and P. T. Vihko Human 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Messenger Ribonucleic Acid Expression and Localization in Term Placenta and in Endometrium during the Menstrual Cycle J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1319 - 1324. [Abstract] [Full Text]

				A. Poletti, P. Negri-Cesi, M. Rabuffetti, A. Colciago, F. Celotti, and L. Martini Transient Expression of the 5{alpha}-Reductase Type 2 Isozyme in the Rat Brain in Late Fetal and Early Postnatal Life Endocrinology, April 1, 1998; 139(4): 2171 - 2178. [Abstract] [Full Text] [PDF]

				M. S. Mahendroo, K. M. Cala, C. P. Landrum, and D. W. Russell Fetal Death in Mice Lacking 5{alpha}-Reductase Type 1 Caused by Estrogen Excess Mol. Endocrinol., June 1, 1997; 11(7): 917 - 927. [Abstract] [Full Text]

				F. W. George Androgen Metabolism in the Prostate of the Finasteride-Treated, Adult Rat: A Possible Explanation for the Differential Action of Testosterone and 5{alpha}-Dihydrotestosterone during Development of the Male Urogenital Tract Endocrinology, March 1, 1997; 138(3): 871 - 877. [Abstract] [Full Text] [PDF]

				H Tian, S L McKnight, and D W Russell Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes & Dev., January 1, 1997; 11(1): 72 - 82. [Abstract] [PDF]